Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Programming

Health care delivery (1)

Filter by Specific Population

Filter by Topic

Filter by Infection

HIV (remove)
Hepatitis C (1)

Filter by Resource Category

Search results

Current filters: HIV drugs, HIV

164 search results

1
2
3
4
5

Biktarvy begins to get listed on provincial drug formularies: From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage
Dovato approved in Canada for HIV treatment: 2019, CATIE
Research summary - Webpage
Update of recommendations on first- and second-line antiretroviral regimens: 2019, World Health Organization (WHO)
Guideline or manual - PDF
More info
Truvada vs. Descovy for HIV prevention: From TreatmentUpdate 231
2019, CATIE
Research summary - Webpage
Higher levels of dolutegravir in older people not linked to side effects: From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage
Large French study examines neuropsychiatric side effects with integrase inhibitors: From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage
Can high-dose dolutegravir be a rescue therapy?: From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage
Delstrigo: 2019, CATIE
Fact sheet - Webpage
De-simplifying single-tablet regimens for HIV treatment: 2019, CATIE
Research summary - Webpage
Pifeltro (doravirine): 2019, CATIE
Fact sheet - Webpage

1
2
3
4
5

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.